Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma

Sorafenib may prolong survival in patients with advanced hepatocellular carcinoma (HCC), but with limited efficacy. The present study aimed to prospectively investigate the efficacy and analyze the prognostic factors for survival in sorafenib-treated patients with advanced HCC. The baseline characte...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: WANG, CHUNPING, LU, YINYING, WANG, HONG, GAO, XUDONG, BAI, WENLIN, QU, JIANHUI, XU, GUILIN, ZHANG, ZHENZHEN, ZENG, ZHEN, ZHOU, LIN, AN, LINJING, LV, JIYUN, YANG, YONGPING
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2012
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460293/
https://ncbi.nlm.nih.gov/pubmed/23139708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.569
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki